Other
Plaque
0
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Plaque is an early-stage landscape with 0 programs across 3 companies. The most active players are Pfizer, Merck & Co., Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
33
clinical trials
Completed24 · 73%
Unknown status5 · 15%
Terminated3 · 9%
Not yet recruiting1 · 3%
Clinical Trials
Trial Activity
33 trials
Train New Examiners Via Modified Gingival Margin Plaque
Completed·—·Phase 3·NCT00758563·15 enrolled
Evaluating Commercial Anti-Plaque Products and Oral Rinse
Completed·—·Phase 2·NCT01014143·26 enrolled
Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples
Completed·—·Phase 2·NCT05138978·34 enrolled
Effect of Evolocumab on Coronary Plaque Characteristics
Completed·—·Phase 4·NCT04710368·137 enrolled
Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.
Completed·—·Phase 3·NCT00966953·25 enrolled
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Completed·—·Phase 4·NCT01567826·87 enrolled
Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent
Completed·—·Phase 4·NCT00589732·220 enrolled
Effect on Bacterial Glycolytic Acid Formation on Plaque
Completed·—·Phase 3·NCT00762450·6 enrolled
A Study to Evaluate Sampling Methods for Subgingival Plaque
Completed·—·N/A·NCT02841839·20 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)